Navigation Links
Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
Date:10/31/2007

LAUSANNNE, Switzerland and CHIBA, Japan, October 31 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in oncology and serious medical conditions, and NanoCarrier Co., Ltd. (NanoCarrier) today announced the signature of a License and Supply Agreement for DACH-Platin Polymeric Micelle (Debio 0507/NC-4016), MediCelle(TM) technology, owned by NanoCarrier, currently in late preclinical development by Debiopharm for use in oncology. Phase I clinical studies are expected to start in 2008 in Europe and / or USA.

Under the terms of the agreement:

- NanoCarrier grants Debiopharm an exclusive license, with the right to sublicense, develop and commercialize DACH-Platin Polymeric Micelle worldwide excluding Japan.

- Debiopharm will provide NanoCarrier exclusively with the starting material of DACH-platin, and NanoCarrier will manufacture and provide DACH-Platin Polymeric Micelle solely to Debiopharm.

- Debiopharm will cover costs related to the manufacture of DACH-Platin Polymeric Micelle and will pay NanoCarrier an up-front and milestones, as well as running royalties for the license.

- NanoCarrier will pay Debiopharm for the use of Debiopharm's data or intellectual property upon registration in Japan.

Debiopharm will be fully responsible for the development of DACH-Platin Polymeric Micelle. The collaboration between the two companies started in 2005, when NanoCarrier granted Debiopharm the exclusive option to license-in a DACH-platin-PEG-polyglutamic acid (DACH Platin MediCelle(TM)) from NanoCarrier, for use in oncology.

About DACH-Platin Micelle

DACH-platin is an active metabolite of Oxaliplatin, which shows stronger anticancer activity. Oxaliplatin is an anticancer drug effective against progressive and relapsed colon cancer. However, it may cause severe peripheral neuropathy like numbness. Because of its hydrophobic feature, it was difficult to formulate DACH-pl
'/>"/>

SOURCE The Debiopharm Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy to Market Debiopharms New Drug in India
2. Georgia: Indian doctors license cancelled
3. US Government Licenses New Hypertension Drug
4. Proposal to license Ayurveda Practitioners in the US
5. Genomatix Licensed By Bayer Healthcare
6. Panacea Biotec In-Licenses FMD Vaccine
7. Test for Esophageal Reflux Licensed to Bayer by University
8. Thailand Goes Ahead With Licenses for Generic Drugs
9. Swedish Biotech Licenses HIV Drug to China for Development
10. More Foreign Trained Doctors Receive Licenses
11. FDA Licenses First US Vaccine Against Avian Flu

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... New book called "Prevent...ot; by Dr. Roberto Giraldo shows that AIDS is a re... a variety of so-called immune system stressor age...tional and most of all, emotional. , ...-- From Nov. 6 – 8, 2009, cell biologists, p...
(Date:11/8/2009)... WASHINGTON, Nov. 7 Tod..., Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and ...for America Act" (H.R. 3962). The amendment mainta...ng for abortion and for benefits packages that inc... those who receive affordability credits and those...
(Date:11/8/2009)... Calls for Swift Passage of H.R. 3961 to Secure t...RNewswire-USNewswire/ -- Statement Attributable to...al Association. ,, (Logo: http://www.newscom....MA hails the passage of the House health reform bi...patients and physicians and calls for swift passag...
(Date:11/8/2009)... HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNewswire/...ation of Babies luncheon to recognize prominent in...hildren and who are role models for March of Dimes...art of the March of Dimes November Prematurity Awa...sts were urged to join the fight for preemies! ,...
(Date:11/7/2009)... Jacquelyn T. Coleman (CT), David A. Cook (GA), L...L. Tarver (LA) Honored ,, CHICAGO, Nov. 7 /PRN...ation (AMA) today presented five medical society e...their contributions to the goals and ideals of the...the AMA,s semi-annual policy making meeting in Hou...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2
... announced a ban on the anti-inflammatory drug Bex...e benefits derived from the drug were outweighed b...ity of // triggering strokes and heart attacks, ac...ithdrawn the drug which belongs to the cox-2 inhib...
...ada are raising a hue and cry over inadequate faci...R at provincial hospitals// are ill-equipped and m...leries. At a meeting of the PHSA in Vancouver t...acy and no direct access to a washroom, or a bell ...
...Johns Hopkins are reporting that the traditional m...in women are fraught with the danger //of missing ...coronary heart disease (CHD). Roger Blumenth... Heart Institute has authored two reports delving ...
...es in Australia’s Townsville will be revolutionize...en to the James Cook University (JCU).// A rural m...tt, the Health Minister, at JCU. The University’s ...edicine in remote and rural communities. There are...
...d to Food science and consumer acceptance in Norwa...eact differently then do experts to cheese.// ...consumers were compared with expert dairy assessor...searchers highlight the importance of recognizing ...
...the Pennsylvania State University are trying to de...icans, through studying the zebra fish. The team l...ra fish //and found a small change in their key ge... European descent have a lighter skin than those f...
Other Medicine News:Health News:Calcium Levels Could Indicate Future Heart Disease Risk 2
(Date:11/6/2009)...wswire/ -- Philips Respironics applauds the effort...n (CDC) to raise awareness about an important publ...e CDC,s release of the first-ever government study...sness is a milestone in quantifying the size and s...r, industry leader and sleep therapy manufacturer,...
(Date:11/6/2009)...Nov. 6 Chimerix, Inc., a biopharma...ral therapeutics to address life-threatening disea...ompany,s lead antiviral compound, CMX001, to the W...th Security Initiative (GHSI). CMX001 is a broad-...reatment of smallpox, as well as other serious vir...
(Date:11/6/2009)...rstCall/ -- Caraco Pharmaceutical Laboratories, Lt...thamine ophthalmic solution, 0.5% following a fina...n (FDA) for Sun Pharma,s Abbreviated New Drug Appl...solution on the first day following patent expirat... equivalent to Acular® Ophthalmic Solution, 0...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Epygi Technologies Partners with FaxBack to Incorporate Microsoft Fax into Epygi 26apos 3Bs VoIP Phone Systems 55964 1Epygi Technologies Partners with FaxBack to Incorporate Microsoft Fax into Epygi 26apos 3Bs VoIP Phone Systems 55964 2Epygi Technologies Partners with FaxBack to Incorporate Microsoft Fax into Epygi 26apos 3Bs VoIP Phone Systems 55964 3Epygi Technologies Partners with FaxBack to Incorporate Microsoft Fax into Epygi 26apos 3Bs VoIP Phone Systems 55964 4Traveling With Diabetes The Positive Way 55962 1Traveling With Diabetes The Positive Way 55962 2Traveling With Diabetes The Positive Way 55962 3Lexi Comp Inc Receives NorthCoast 99 Honor 55960 1Lexi Comp Inc Receives NorthCoast 99 Honor 55960 2Lexi Comp Inc Receives NorthCoast 99 Honor 55960 3Lexi Comp Inc Receives NorthCoast 99 Honor 55960 4
...ons Learned from the Avandia Controversy, ALEXAND...abetes live longer when they are treated for depre...f Diabetes Care, which,publishes on November 27, 2...rial by U.S. Food and Drug,Administration (FDA) Me...ons learned from the recent Avandia controversy an...
... Nov. 26 CSL Behring announced,today that it has ...al,trial of human pasteurized C1-inhibitor (C1-INH...gioedema (HAE), a rare genetic disorder that can,l...cks of edema (swelling),of the face, airway, abdom...III, double blind, placebo-controlled trial,I.M.P....
Other Medicine Technology:Treating Depression Prolongs Life for Older People with Diabetes 2CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema 2CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema 3CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema 4
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Atlas Wire™ Stone Extractors - RHR Replacement Stone Extractors
Captura® Helical Stone Extractor - RHR Replacement Stone Extractors
Kidney Internal Splint Stent Sets
Medicine Products: